NCT03638882

Brief Summary

Bilingualism has been shown to have a strong protective effect against dementia, delaying the diagnosis of Alzheimer's disease by up to 4 years. The purpose of the study is to test whether learning a second language using Duolingo software could improve cognitive functions in older adults.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2018

Completed
28 days until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 20, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

September 19, 2019

Status Verified

September 1, 2019

Enrollment Period

1.8 years

First QC Date

July 4, 2018

Last Update Submit

September 18, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in working memory, n-back

    Working memory assessed by the n-back test

    change from baseline to 16 weeks

  • Change in inhibitory Control, Simon task

    Inhibitory control assessed by the Simon task

    change from baseline to 16 weeks

  • Change in inhibitory Control, DKEFS

    DKEFS Colour Word Interference

    change from baseline to 16 weeks

Secondary Outcomes (4)

  • Change in attention abilities

    change from baseline to 16 weeks

  • Change in language abilities

    change from baseline to 16 weeks

  • change in verbal fluency

    change from baseline to 16 weeks

  • executive function assessed by trailmaking test

    change from baseline to 16 weeks

Other Outcomes (1)

  • Spanish Proficiency (Duolingo group only)

    change from baseline to 16 weeks

Study Arms (3)

Duolingo Spanish Course

EXPERIMENTAL

30 minutes each day, 5 days a week for 16 weeks. Total of 40 hours.

Behavioral: Duolingo

BrainHQ

ACTIVE COMPARATOR

30 minutes each day, 5 days a week for 16 weeks. Total of 40 hours.

Behavioral: BrainHQ

Passive Control

PLACEBO COMPARATOR

No intervention.

Behavioral: Passive Control

Interventions

DuolingoBEHAVIORAL

Will learn Spanish using the commercially available Duolingo application. It is a computerized language training program.

Duolingo Spanish Course
BrainHQBEHAVIORAL

Will use the commercially available Posit Science product Brain HQ. Brain HQ is a computerized adaptive cognitive brain training program.

BrainHQ
Passive ControlBEHAVIORAL

No Intervention.

Passive Control

Eligibility Criteria

Age65 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Participants must have normal vision and hearing.
  • Participants must be able to travel to Baycrest by personal or study-arranged automobile, or public transportation.
  • Participants must be monolingual native English speakers.
  • Participants must be willing to provide informed consent.
  • Participants must have daily access to a smartphone/mobile device.
  • Have not previously studied Spanish formally, nor any other language in the past 10 years.

You may not qualify if:

  • have a neurological disorder.
  • meet DSM-IV-TR criteria for Axis I mood, anxiety, or psychotic or substance abuse disorders.
  • Fluent in more than one language.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baycrest Health Sciences

Toronto, Ontario, M6A 2E1, Canada

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Neurorehabilitation Scientist

Study Record Dates

First Submitted

July 4, 2018

First Posted

August 20, 2018

Study Start

August 1, 2018

Primary Completion

June 1, 2020

Study Completion

October 1, 2020

Last Updated

September 19, 2019

Record last verified: 2019-09

Locations